Withdrawal outcome and persistence were determined by plasma benzodiazepine-determinations at baseline and at four weeks ( `` short-term withdrawers '' , n = 69 ; `` short-term non-withdrawers '' , n = 20 ) , and by interviews at six months ( `` long-term withdrawers '' , n = 34 ; `` long-term non-withdrawers '' , n = 55 ) .